Regen BioPharma, Inc. (RGBP) 은(는) 상장 기업입니다 헬스케어 섹터의 바이오 산업에서 운영. 본사 소재지는 La Mesa, CA, 미국. 현재 CEO는 David Raymond Koos.
RGBP 을(를) 보유 IPO 날짜 2014-10-06, 1 명의 정규직 직원, 에 상장 Other OTC, 시가총액 $18.93K.
Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It engages in actively identifying small molecules that inhibit or express NR2F6 leading to immune cell activation for oncology applications, and immune cell suppression for autoimmune disease. The company is in the early stages of development of its products, and therapies. Regen BioPharma, Inc. was incorporated in 2012 and is based in La Mesa, California.
